Nuclear receptor vitamin D receptor (VDR) regulates most of the biological actions of the active vitamin D metabolite, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3). VDR is highly expressed in intestine and is a critical regulator of proliferation and differentiation, intestinal barrier function, innate immunity, and host defense in the gut. Evidence strongly supports a protective effect of vitamin D and VDR in inflammatory bowel diseases (IBD). Emerging evidence demonstrates low VDR expression and dysfunction of vitamin D/VDR signaling in patients with IBD. In the current review, we summarize recent progress made in vitamin D/VDR signaling in genetic regulation, immunity, and microbiome in both ulcerative colitis and Crohn’s disease. We cover the mechanisms of intestinal VDR in regulating inflammation through inhibiting the NF-κB pathway and activating autophagy. Recent studies suggest that the association of VDR SNPs with immune and intestinal pathology may be gender-dependent. We emphasize the tissue specificity of VDR and its gender and time-dependent effects. Furthermore, we discuss potential clinical application and future direction of vitamin D/VDR in prevention and treatment of IBD.